|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01498 PURAPHARM
Nominal 
0.750 +0.010 (+1.351%) | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 2019/12 |
Profitability Analysis
| ROAA (%) | -11.404 | -10.819 | -9.446 | 2.442 | -17.787 |
| ROAE (%) | -51.555 | -36.437 | -26.692 | 7.258 | -49.172 |
| Return on Capital Employed (%) | -38.875 | -34.240 | -22.547 | 4.051 | -38.970 |
Margin Analysis
| Gross Profit Margin (%) | 53.244 | 58.630 | 64.184 | 61.472 | 57.314 |
| EBITDA Margin (%) | -6.504 | -10.448 | -6.123 | 18.979 | -17.644 |
| Pre-tax Profit Margin (%) | -25.147 | -26.599 | -17.767 | 6.683 | -31.061 |
| Net Profit Margin (%) | -26.073 | -26.829 | -18.478 | 5.269 | -32.658 |
Liquidity Analysis
| Current Ratio (X) | 0.612 | 0.730 | 0.918 | 1.027 | 0.935 |
| Quick Ratio (X) | 0.305 | 0.471 | 0.669 | 0.722 | 0.621 |
Leverage Analysis
| Total Liabilities / Total Assets(%) | 81.843 | 74.590 | 66.700 | 62.777 | 70.372 |
| Total Liabilities / Shareholders' Funds (%) | 450.760 | 293.550 | 200.296 | 168.652 | 237.521 |
| Non-current Liabilities / Shareholders' Funds (%) | 78.074 | 35.930 | 34.613 | 52.971 | 61.040 |
| Interest Coverage Ratio (X) | N/A | N/A | N/A | 2.499 | N/A |
Efficiency Analysis
| Inventory Turnover on Sales (Day) | 156.088 | 137.839 | 95.779 | 115.542 | 108.816 |
| Remarks: | Real time quote last updated: 24/04/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders ($) | HKD -106,081,000 |
| %Change | -11.757% |
| EPS / (LPS) | HKD -0.269 |
| NBV Per Share ($) | HKD 0.387 |